NSIA-LUTH Cancer Center, Lagos University Teaching Hospital, Lagos, Nigeria.
Cancer Care and Research Center, Department of Oncology, Marshfield Clinic Health System, Marshfield, Wisconsin, USA.
Clin Med Res. 2024 Jun;22(2):61-75. doi: 10.3121/cmr.2024.1854.
To explore the association between COVID-19-related cancer treatment cancellations and the psychological health of cancer patients in Nigeria. We analyzed data collected from 15 outpatient cancer clinics, comprising 1,097 patients between April to July 2020. Study outcome was ten psychological impacts, including feeling down, stressed, and unable to access treatment due to COVID-19 (used as continuous and categorical variable (0-3,4-7,8+ events). The independent variable was treatment cancellations due to COVID-19 categorized as 0, 1, and 2+ cancellations. Confounders included religion, ethnicity, income, cancer diagnosis/type, and treatment received. Stata/SE.v.17 was used to perform all analyses. values of ≤0.05 were deemed statistically significant. Of the 1,097 cancer patients, 65.7% were female, with a mean age (SD) of 49.4 (13.8) years. Most patients (50.3%) reported four to seven psychological health events. Cancer patients who reported two/more treatment cancellations made up only 12.8% of the study sample but accounted for a greater proportion of psychological impacts (23.5%; <0.001). In the adjusted model, cancer patients with one treatment cancellation (Coef: 0.195, 95%CI: 0.089-0.302) and those with two/more cancellations (Coef: 0.379, 95%CI: 0.255-0.504) had a significantly higher risk of psychological health impacts than those with no treatment cancellations. More than half of our sample of primarily adult female cancer patients reported major psychological health effects due to COVID-19. Cancer patients who experienced at least one treatment cancellation had a higher risk of psychological health consequences than those who did not. The implications of our findings and how to mitigate the impact of COVID-19 on oncology service disruptions are discussed.
探讨尼日利亚 COVID-19 相关癌症治疗取消与癌症患者心理健康之间的关联。我们分析了 2020 年 4 月至 7 月期间从 15 家门诊癌症诊所收集的数据,共包含 1097 名患者。研究结果为 10 种心理影响,包括因 COVID-19 而感到沮丧、压力大、无法接受治疗(用作连续和分类变量(0-3、4-7、8+事件)。自变量是 COVID-19 导致的治疗取消,分为 0、1 和 2+取消。混杂因素包括宗教、种族、收入、癌症诊断/类型和接受的治疗。使用 Stata/SE.v.17 进行所有分析。≤0.05 的 值被认为具有统计学意义。在 1097 名癌症患者中,65.7%为女性,平均年龄(标准差)为 49.4(13.8)岁。大多数患者(50.3%)报告有 4-7 种心理健康事件。报告 2 次/以上治疗取消的癌症患者仅占研究样本的 12.8%,但占心理影响的比例较大(23.5%;<0.001)。在调整后的模型中,有一次治疗取消的癌症患者(Coef:0.195,95%CI:0.089-0.302)和有两次/以上取消的癌症患者(Coef:0.379,95%CI:0.255-0.504)患心理健康影响的风险明显高于无治疗取消的患者。我们样本中的大多数主要为成年女性癌症患者因 COVID-19 报告了主要的心理健康影响。经历至少一次治疗取消的癌症患者比未经历治疗取消的患者更有可能产生心理健康后果。讨论了我们研究结果的意义以及如何减轻 COVID-19 对肿瘤学服务中断的影响。